每經AI快訊，南(nan)微醫學（SH 688029，收盤(pan)價：94.14元）8月12日(ri)(ri)晚間(jian)發布公(gong)(gong)(gong)(gong)(gong)(gong)(gong)告(gao)稱(cheng)，截(jie)至本(ben)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)告(gao)日(ri)(ri)，南(nan)京新微創企業管理咨詢有(you)(you)限公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)持(chi)(chi)(chi)(chi)(chi)有(you)(you)南(nan)微醫學科技股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)有(you)(you)限公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)約4307萬(wan)股(gu)(gu)(gu)(gu)(gu)，占(zhan)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)總股(gu)(gu)(gu)(gu)(gu)本(ben)的(de)(de)(de)23.0004%。相關股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)來源為(wei)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)首次(ci)(ci)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)開發行(xing)(xing)股(gu)(gu)(gu)(gu)(gu)票并上市前取得的(de)(de)(de)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)，且已于(yu)2022年7月22日(ri)(ri)起上市流通(tong)。公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)東微創咨詢因(yin)自(zi)身(shen)資(zi)金需求，擬通(tong)過(guo)(guo)上海證(zheng)券交(jiao)(jiao)易(yi)(yi)所(suo)交(jiao)(jiao)易(yi)(yi)系(xi)統以集中競價、大(da)宗(zong)交(jiao)(jiao)易(yi)(yi)方(fang)(fang)(fang)式(shi)(shi)減持(chi)(chi)(chi)(chi)(chi)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)合計(ji)(ji)不(bu)超(chao)過(guo)(guo)約506萬(wan)股(gu)(gu)(gu)(gu)(gu)，其中擬通(tong)過(guo)(guo)證(zheng)券交(jiao)(jiao)易(yi)(yi)所(suo)集中競價交(jiao)(jiao)易(yi)(yi)方(fang)(fang)(fang)式(shi)(shi)進(jin)行(xing)(xing)減持(chi)(chi)(chi)(chi)(chi)的(de)(de)(de)，將(jiang)于(yu)減持(chi)(chi)(chi)(chi)(chi)計(ji)(ji)劃公(gong)(gong)(gong)(gong)(gong)(gong)(gong)告(gao)披露之(zhi)日(ri)(ri)起15個(ge)交(jiao)(jiao)易(yi)(yi)日(ri)(ri)之(zhi)后(hou)的(de)(de)(de)90日(ri)(ri)內(nei)減持(chi)(chi)(chi)(chi)(chi)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)不(bu)超(chao)過(guo)(guo)約187萬(wan)股(gu)(gu)(gu)(gu)(gu)，且任(ren)意(yi)連續(xu)90個(ge)自(zi)然(ran)日(ri)(ri)內(nei)通(tong)過(guo)(guo)交(jiao)(jiao)易(yi)(yi)所(suo)集中競價方(fang)(fang)(fang)式(shi)(shi)減持(chi)(chi)(chi)(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)的(de)(de)(de)總數，不(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總數的(de)(de)(de)1%；擬通(tong)過(guo)(guo)大(da)宗(zong)交(jiao)(jiao)易(yi)(yi)方(fang)(fang)(fang)式(shi)(shi)減持(chi)(chi)(chi)(chi)(chi)的(de)(de)(de)，將(jiang)于(yu)本(ben)減持(chi)(chi)(chi)(chi)(chi)計(ji)(ji)劃披露之(zhi)日(ri)(ri)起3個(ge)交(jiao)(jiao)易(yi)(yi)日(ri)(ri)之(zhi)后(hou)的(de)(de)(de)90日(ri)(ri)內(nei)減持(chi)(chi)(chi)(chi)(chi)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)不(bu)超(chao)過(guo)(guo)約319萬(wan)股(gu)(gu)(gu)(gu)(gu)，且任(ren)意(yi)連續(xu)90個(ge)自(zi)然(ran)日(ri)(ri)內(nei)通(tong)過(guo)(guo)大(da)宗(zong)交(jiao)(jiao)易(yi)(yi)方(fang)(fang)(fang)式(shi)(shi)減持(chi)(chi)(chi)(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總數不(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)總數的(de)(de)(de)2%。本(ben)次(ci)(ci)擬通(tong)過(guo)(guo)以上兩種方(fang)(fang)(fang)式(shi)(shi)減持(chi)(chi)(chi)(chi)(chi)的(de)(de)(de)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)合計(ji)(ji)不(bu)超(chao)過(guo)(guo)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)總股(gu)(gu)(gu)(gu)(gu)本(ben)比(bi)例約2.70%。若減持(chi)(chi)(chi)(chi)(chi)期間(jian)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)有(you)(you)送(song)股(gu)(gu)(gu)(gu)(gu)、資(zi)本(ben)公(gong)(gong)(gong)(gong)(gong)(gong)(gong)積(ji)金轉(zhuan)增股(gu)(gu)(gu)(gu)(gu)本(ben)等股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)變動事項(xiang)，減持(chi)(chi)(chi)(chi)(chi)股(gu)(gu)(gu)(gu)(gu)份(fen)(fen)(fen)(fen)數量(liang)進(jin)行(xing)(xing)相應調整(zheng)。

2021年1至12月份，南(nan)微(wei)醫學的營(ying)業收入構成(cheng)為：醫療器械占比(bi)99.76%。

南(nan)微醫學(xue)的董(dong)事長是隆曉(xiao)輝，男(nan)，63歲，學(xue)歷(li)背景(jing)為碩(shuo)士(shi)；總經理是冷德嶸，男(nan)，59歲，學(xue)歷(li)背景(jing)為本科。

截(jie)至發稿，南微醫學市值為176億元(yuan)。

道(dao)達(da)號（daoda1997）“個股趨勢”提醒：
1. 近30日內無機構對南微醫學進行調研；
2. 南微醫學上次發布減持公告是2022年07月30日，第二個交易日上漲4.16%，南微醫學近一年共發布2次減持類公告。
更多個股趨勢信(xin)息，請搜索微信(xin)公眾號(hao)“道達號(hao)”，回復“查詢”，領取免費查詢權限！

每經頭條（nbdtoutiao）——

(記者 蔡鼎)

免責聲明：本文內(nei)容與數據(ju)僅(jin)供參考(kao)，不(bu)構成投(tou)資(zi)建議，使用前請核實。據(ju)此操作，風險(xian)自(zi)擔。